Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
The Institute of Cancer Research
Apr 27, 2024, 09:53 |
Blog
Neeraj Agarwal: Advanced Prostate Cancer Consensus Conference, Fantastic talk by Neha Vapiwala on radiation therapy in high risk Prostate Cancer
Neeraj Agarwal shared on X/Twitter: "Advanced Prostate Cancer Consensus Conference, Fantastic talk by Neha Vapiwala on radiation…
Apr 27, 2024, 07:10 |
Insight
,
Opinion
Benjamin Diamond: Our paper on genomic profiling of high-risk smouldering myeloma now in Clinical Cancer Research
Benjamin Diamond, Assistant Professor of the Myeloma Institute at the Sylvester Comprehensive Cancer Center, shared…
Apr 26, 2024, 18:20 |
Blog
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health nurses present at Oncology Nursing Society Congress
Rutgers Cancer Institute of New Jersey shared on X: "Rutgers Cancer Institute of New Jersey…
Apr 26, 2024, 17:44 |
Drugs
Paolo Tarantino: The agnostic potential of Antibody Drug Conjugates with Roberto Carmagnani Pestana, MD is among the most cited of 2022-2023 on CA - A Cancer Journal for Clinicians
Apr 26, 2024, 16:34 |
Dialogues
Oncothon: ASCO And Cancer Drug Development
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
Apr 26, 2024, 12:00 |
Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Apr 26, 2024, 11:03 |
Blog
Vivek Subbiah: FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
Vivek Subbiah shared a post on X: "FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive…
Apr 26, 2024, 08:37 |
Blog
Karen Knudsen: A huge thank you to the 74 CEOs who participated in our one-day Fit2BeCancerFree CEO Challenge
Karen Knudsen shared on X/Twitter: ''A huge thank you to the 74 CEOs who participated in…
Apr 26, 2024, 07:04 |
Blog
Rudi Schmidt: The PD1/PD-L1 checkpoint pathway is almost exclusively associated with cancer and immunotherapies
Rudi Schmidt, Chief Operating Officer at Institute for Healthier Living Abu Dhabi, shared on LinkedIn:…
Apr 25, 2024, 20:52 |
Dialogues
Oncothon: Pediatric Cancer Drug Development
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
77
78
79
80
81
All:
2676
Posts:
781 - 790
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube